- Report
- January 2025
- 180 Pages
Global
From €5704EUR$5,950USD£4,766GBP
- Report
- August 2024
- 185 Pages
Global
From €4314EUR$4,500USD£3,605GBP
- Report
- October 2024
Global
From €3355EUR$3,500USD£2,804GBP
- Report
- December 2021
Global
From €4650EUR$4,850USD£3,885GBP
The Calprotectin Test is a type of Infectious Disease Testing used to detect the presence of inflammation in the body. It is a non-invasive test that measures the amount of calprotectin, a protein found in white blood cells, in a patient's stool sample. The test is used to diagnose and monitor inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. It can also be used to differentiate between inflammatory and non-inflammatory causes of gastrointestinal symptoms.
The Calprotectin Test market is a growing segment of the Infectious Disease Testing industry. It is used by healthcare providers to diagnose and monitor inflammatory bowel diseases, as well as to differentiate between inflammatory and non-inflammatory causes of gastrointestinal symptoms. The test is also used to monitor the effectiveness of treatments for inflammatory bowel diseases.
Some companies in the Calprotectin Test market include Abbott Laboratories, Becton Dickinson, Bio-Rad Laboratories, Cepheid, DiaSorin, and Roche Diagnostics. Show Less Read more